ArticleEuropean radiology2026
A deep learning framework to stratify Nottingham histologic grade 2 breast tumors based on dynamic contrast-enhanced MRI.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Automated calculation of background parenchymal enhancement as a biomarker of treatment responses and recurrence-free survival in breast cancer.Breast cancer research and treatment · 2026Article
- Review of Prognostic Significance of Quantitative BPE Measurements.Diagnostics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe Nottingham Histologic Grade (NHG) informs prognosis and treatment decisions in breast cancer, but NHG2 tumors are biologically heterogeneous, leading to both under- and over-treatment. MATERIALS AND
methodsClinical and imaging data from the Duke-Breast-Cancer-MRI (n = 877) and advanced-MRI-breast-lesions (n = 37) datasets were used to develop DeepRadGrade (DRG), a convolutional neural network model trained to differentiate NHG1 from NHG3 tumors on dynamic contrast-enhanced (DCE) MRI. The model then classified 456 NHG2 tumors into DRG2- (NHG1-like) and DRG2+ (NHG3-like) subgroups. Recurrence-free survival (RFS) was assessed with Kaplan-Meier and Cox models adjusting for age, lymph node invasion, tumor stage, and molecular subtype.
resultsDRG achieved an AUC of 0.84 [95% CI: 0.83-0.86] in training, 0.82 [0.71-0.91] in testing, and 0.84 [0.69-0.96] in external validation. Among NHG2 tumors, 315 were classified as DRG2- and 131 as DRG2+. Patients with DRG2+ tumors had significantly worse RFS compared to DRG2- (adjusted hazard ratio = 2.39 [95% CI: 1.29-4.45], p = 0.0059), independent of standard prognostic factors. Incorporating DRG classification improved the Cox model's C-index from 0.68 to 0.73 (p = 0.040).
conclusionsA deep learning model applied to routine DCE MRI effectively stratified NHG2 breast tumors into clinically meaningful subgroups with distinct recurrence risk. This approach offers a cost-effective tool for individualized risk stratification and could help tailor treatment to minimize over- and under-treatment in intermediate-grade breast cancer. KEY POINTS: Question Difficulty in deciding between treatment options (neoadjuvant chemotherapy or primary surgery) in patients with intermediate risk breast cancer (Nottingham Grade 2). Findings Deep learning model reclassified grade 2 tumors into grade 1- and 3-like based on MRI. Patients with grade 3-like tumors had worse RFS: adjusted hazard ratio = 2.39 [95% CI: 1.29-4.45], p = 0.0059). Clinical relevance Risk stratification could inform treatment choice to minimize over- and under-treatment in patients with intermediate-risk breast cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.